[Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19].
Kruglova TS, Fomina DS, Poteshkina NG, Frolova NF, Beloglazova IP, Mutovina ZY, Samsonova IV, Kovalevskaja EA, Zagrebneva AI, Serdotetckova SA, Chernov AA, Lysenko MA.
Kruglova TS, et al. Among authors: beloglazova ip.
Ter Arkh. 2021 Nov 15;93(11):1316-1324. doi: 10.26442/00403660.2021.11.201248.
Ter Arkh. 2021.
PMID: 36286654
Russian.